发明名称 Caspase inhibitors and uses thereof
摘要 Described herein are compounds that are useful as caspase inhibitors having the formula:wherein Ring A is an optionally substituted piperidine, tetrahydroquinoline or tetrahydroisoquinoline ring; R<1 >is hydrogen, CN, CHN2, R, or CH2Y; R is an optionally substituted group selected from an aliphatic group, an aryl group, or an aralkyl group; Y is an electronegative leaving group; R<2 >is CO2H, CH2CO2H, or esters, amides or isosteres thereof; and R<3 >is hydrogen, an optionally substituted aryl group, an optionally substituted aralkyl group, or an optionally substituted C1-6 aliphatic group, R<4 >is an optionally substituted group selected from an aryl group or a heterocyclyl group, or R<3 >and R<4 >taken together with the nitrogen to which they are attached optionally form a substituted or unsubstituted monocyclic, bicyclic or tricyclic ring.
申请公布号 AU9079501(A) 申请公布日期 2002.03.26
申请号 AU20010090795 申请日期 2001.09.12
申请人 VERTEX PHARMACEUTICALS INCORPORATED 发明人 JEAN-DAMIEN CHARRIER;RONALD KNEGTEL;MICHAEL MORTIMORE
分类号 A61K31/454;A61K31/473;A61K31/5415;A61P1/04;A61P1/16;A61P3/10;A61P5/14;A61P7/00;A61P7/04;A61P7/06;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/02;A61P17/14;A61P17/16;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P21/04;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P25/32;A61P27/02;A61P29/00;A61P31/00;A61P31/04;A61P31/06;A61P31/12;A61P31/14;A61P31/18;A61P31/20;A61P35/00;A61P35/02;A61P37/06;A61P39/06;A61P41/00;A61P43/00;C07D401/06;C07D413/06;C07D417/06;C07D471/04;C07D495/04;C07D513/04 主分类号 A61K31/454
代理机构 代理人
主权项
地址